| Neurizon Therapeutics Limited (NUZ) ORDINARY FULLY PAID |
Health Care |
$61 |
New Funding Secured for HEALEY ALS Platform Trial
|
23 Dec 2025 9:49AM |
$0.110 |
$0.086 |
fallen by
21.82%
|
|
NUZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Neurizon secured ~$7.1 million from shareholders and investors.
- A $20 million convertible note facility established with Obsidian Global GP, LLC.
- Funding supports participation in HEALEY ALS Platform Trial for NUZ-001.
- Trial aims to treat ALS, the most common form of motor neuron disease.
- Funding combines share placements and strategic financing.
- Participation in the trial starts early Q1 CY2026.
- Trial includes a randomised clinical trial and active treatment extension phases.
- Neurizon aims to explore broader applications for NUZ-001.
- Funding structure minimizes dilution and aligns with clinical milestones.
- The trial is pivotal for future regulatory and commercial initiatives.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Core Lithium Ltd (CXO) ORDINARY FULLY PAID |
Materials |
$992 |
EL8:Acquisition of Napperby Uranium Resource
|
23 Dec 2025 9:48AM |
$0.270 |
$0.340 |
risen by
25.93%
|
|
| Elevate Uranium Ltd (EL8) ORDINARY FULLY PAID |
Energy |
$140 |
Acquisition of Napperby Uranium Resource
|
23 Dec 2025 9:48AM |
$0.270 |
$0.300 |
risen by
11.11%
|
|
EL8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Elevate Uranium Ltd has finalized the acquisition of Uranium Generation Pty Ltd from Core Lithium Ltd.
- The acquisition includes the Napperby Uranium Project in the Northern Territory and additional uranium projects in South Australia.
- The Napperby Project contains a JORC 2012 compliant Mineral Resource of 8.03 Mlb at 382 ppm U3O8.
- The acquisition increases Elevate Uranium's global Mineral Resource inventory to 169 Mlb U3O8.
- The strategy involves applying the U-pgradeâ„¢ process to enhance value from the acquired assets.
- Additional tenements in NT and SA are expected to provide exploration potential.
- A net smelter royalty of 1.0% on production from Napperby is part of the acquisition agreement.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$10 |
Proposed issue of securities - MRQ
|
23 Dec 2025 9:46AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$10 |
Placement to Advance REE and HMS Projects
|
23 Dec 2025 9:45AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
| MRG Metals Limited (MRQ) ORDINARY FULLY PAID |
Materials |
$10 |
MRG Acquires High Grade REE Garies Project in South Africa
|
23 Dec 2025 9:44AM |
$0.004 |
$0.004 |
fallen by
12.50%
|
|
MRQ - Price-sensitive ASX Announcement
Full Release
Key Points
- MRG Metals Limited has acquired the high-grade Garies Rare Earth Elements (REE) Project in South Africa.
- The Garies Project is located close to the Steenkampskraal Monazite Mine, one of the world's highest-grade rare earth projects.
- The project includes a high-value heavy rare earth component, with approximately 9% heavy rare earth oxides (HREO).
- Monazite grades are up to 8%, supporting high-value concentrate pricing.
- The project may support rapid development of a small-scale mine after obtaining a mining license.
- The company plans to use cash flows from its Mozambique Heavy Mineral Sands joint venture to minimize shareholder dilution.
- The Garies Project has a large 275 km² exploration footprint, with 190 km² applied for and awaiting approval.
- Bulk sampling has shown grades up to 4.85% Total Rare Earth Oxides (TREO).
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$86 |
Change of Director's Interest Notice
|
23 Dec 2025 9:43AM |
$0.335 |
$0.385 |
risen by
14.93%
|
|
| Scorpion Minerals Limited (SCN) ORDINARY FULLY PAID |
Materials |
$18 |
OZZ :Binding Option Agreement Executed
|
23 Dec 2025 9:42AM |
$0.025 |
$0.034 |
risen by
36%
|
|
| Ozz Resources Limited (OZZ) ORDINARY FULLY PAID |
Materials |
$5 |
Binding Option Agreement Executed
|
23 Dec 2025 9:42AM |
$0.055 |
$0.055 |
fallen by
0%
|
|
| Sprintex Limited (SIX) ORDINARY FULLY PAID |
Consumer Discretionary |
$53 |
Trading Halt
|
23 Dec 2025 9:41AM |
$0.060 |
$0.075 |
risen by
25%
|
|
SIX - Price-sensitive ASX Announcement
Full Release
Key Points
- Sprintex Limited requested a trading halt for its securities.
- The halt is pending an announcement about a material purchase order.
- Trading halt is effective from 23 December 2025.
- The halt will last until 29 December 2025 or until an announcement is made.
- The request was authorized by the board of directors.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BCI Minerals Limited (BCI) ORDINARY FULLY PAID |
Materials |
$1,146 |
Primary Approvals Received for Optimised Dredge Strategy
|
23 Dec 2025 9:40AM |
$0.385 |
$0.390 |
risen by
1.30%
|
|
BCI - Price-sensitive ASX Announcement
Full Release
Key Points
- BCI Minerals secures primary governmental approvals for optimised dredge strategy.
- Approvals provided under both Commonwealth and Western Australian environmental laws.
- Dredging program to support the Mardie Salt Operation at Cape Preston West Port.
- Dredging expected to start in April 2026, with first salt shipment by December 2026.
- The approvals enhance project scheduling and budget management, mitigating risks.
- The initiative positions BCI as a significant player in the global industrial salt market.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Kairos Minerals Limited (KAI) ORDINARY FULLY PAID |
Materials |
$161 |
More Outstanding Drill Hits at Mt York
|
23 Dec 2025 9:38AM |
$0.033 |
$0.715 |
risen by
2,066.67%
|
|
KAI - Price-sensitive ASX Announcement
Full Release
Key Points
- Kairos Minerals Limited (ASX:KAI) announced more outstanding drill results at Mt York.
- Drill results include significant intercepts such as 51m at 2.42 g/t Au from 54m at Main Hill.
- Results from 12 additional holes at Main Hill and Breccia Hill prospects were reported.
- The 2025 drilling campaign at Mt York was completed with 26,971 meters drilled.
- Kairos expects these results to positively impact the Mt York Mineral Resource Estimate (MRE) in Q1 2026.
- The company has a cash balance of $30.4M following recent fundraising.
- Geologists reported sulphide-bearing BIF at the Mt York Extension.
- The drilling program used historic PLS reconnaissance data for drill hole positioning.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Invion Limited (IVX) ORDINARY FULLY PAID |
Health Care |
$6 |
Hanlim & Korean Government Fund Pathway to Clinical Trial
|
23 Dec 2025 9:37AM |
$0.081 |
$0.060 |
fallen by
25.93%
|
|
IVX - Price-sensitive ASX Announcement
Full Release
Key Points
- Non-dilutive funding secured from Hanlim Pharm and KDDF.
- Two-stage development program worth up to A$2 million.
- Stage 1: Efficacy studies in oesophageal cancer animal models.
- Stage 2: Preparation for human trials in Australia.
- Significant market opportunity due to unmet needs in oesophageal cancer.
- Partnership aims to advance Photosoft technology for cancer treatment.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Artrya Limited (AYA) ORDINARY FULLY PAID |
Health Care |
$682 |
Cone Health Becomes Third U.S. Customer
|
23 Dec 2025 9:35AM |
$3.860 |
$4.270 |
risen by
10.62%
|
|
AYA - Price-sensitive ASX Announcement
Full Release
Key Points
- Artrya Limited has signed a five-year commercial agreement with Cone Health as its third U.S. commercial customer.
- The agreement involves the use of Artrya's Salix® Coronary Anatomy platform on a SaaS basis with a fixed monthly subscription fee.
- Cone Health is a leading not-for-profit health system in North Carolina with a network of numerous healthcare facilities.
- Artrya's technology allows for point-of-care interpretation of CCTA scans within minutes, aiding in faster diagnoses.
- The integration of the Salix® platform is managed by Artrya's Customer Success team in Atlanta, Georgia.
- The commercial agreement allows for fee-per-scan revenue using the Salix® Coronary Plaque module.
- Artrya has successfully converted all three of its U.S. foundation partners to commercial customers by 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Echelon Resources Limited (ECH) ORDINARY FULLY PAID |
Energy |
$86 |
Notification regarding unquoted securities - ECH
|
23 Dec 2025 9:35AM |
$0.335 |
$0.385 |
risen by
14.93%
|
|
| Cobre Ltd (CBE) ORDINARY FULLY PAID |
Materials |
$163 |
Change of Director's Interest Notice
|
23 Dec 2025 9:34AM |
$0.095 |
$0.170 |
risen by
78.95%
|
|
| Simble Solutions Limited (SIS) ORDINARY FULLY PAID |
Information Technology |
$16 |
Trading Halt
|
23 Dec 2025 9:34AM |
$0.005 |
$0.007 |
risen by
40%
|
|
SIS - Price-sensitive ASX Announcement
Full Release
Key Points
- Simble Solutions Ltd requests a trading halt for its securities.
- The halt is related to a pending announcement about a material acquisition and capital raising.
- The trading halt is expected to last until the announcement is made or until trading resumes on 29 December 2025.
- Simble confirms compliance with continuous disclosure obligations under Listing Rule 3.1.
- No reasons against the trading halt are noted by the company.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WCM Global Growth Limited (WQG) ORDINARY FULLY PAID |
Financials |
$483 |
Weekly NTA 19 December 2025
|
23 Dec 2025 9:33AM |
$1.965 |
$1.750 |
fallen by
10.94%
|
|
| Lowell Resources Fund (LRT) ORDINARY UNITS FULLY PAID |
Financials |
$107 |
LRT NAV Estimate - 19 December 2025
|
23 Dec 2025 9:33AM |
$2.200 |
$2.580 |
risen by
17.27%
|
|
| Cazaly Resources Limited (CAZ) ORDINARY FULLY PAID |
Materials |
$14 |
High Grade Gold from Surface in Drilling at Goongarrie
|
23 Dec 2025 9:32AM |
$0.030 |
$0.023 |
fallen by
23.33%
|
|
CAZ - Price-sensitive ASX Announcement
Full Release
Key Points
- High-grade gold mineralisation intersected at the Goongarrie Gold Project.
- Significant gold intercepts include 4m @ 6.6 g/t from surface and 4m @ 5.7 g/t from 12m.
- 240 holes were drilled for a total of 7,604m in the Aircore drilling program.
- A 1,300m strike of high-grade mineralisation delineated.
- RC drill program scheduled for early 2026 to test extensions of high-grade zones.
- Cazaly Resources has agreements to earn interest in the Goongarrie project covering 15 tenements.
- Cazaly aims to earn up to an 80% interest through staged exploration expenditure.
- Cazaly's forward-looking statements highlight plans for ongoing exploration and potential risks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$455 |
Application for quotation of securities - AIS
|
23 Dec 2025 9:31AM |
$0.555 |
$0.380 |
fallen by
31.53%
|
|
| Siren Gold Limited (SNG) ORDINARY FULLY PAID |
Materials |
$23 |
Notification of cessation of securities - SNG
|
23 Dec 2025 9:31AM |
$0.095 |
$0.075 |
fallen by
21.05%
|
|
| TG Metals Limited (TG6) ORDINARY FULLY PAID |
Materials |
$18 |
Strong Drilling Results Continue at Van Uden
|
23 Dec 2025 9:31AM |
$0.180 |
$0.150 |
fallen by
16.67%
|
|
TG6 - Price-sensitive ASX Announcement
Full Release
Key Points
- ASX announcement released on 23 December 2025.
- Strong drilling results at the Van Uden project.
- Significant gold grades recorded at Van Uden South.
- Ongoing drilling operations with detailed hole identifications.
- Potential for further exploration and development.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BCI Minerals Limited (BCI) ORDINARY FULLY PAID |
Materials |
$1,146 |
Conversion of Series 1 Notes
|
23 Dec 2025 9:30AM |
$0.385 |
$0.390 |
risen by
1.30%
|
|
| Rox Resources Limited (RXL) ORDINARY FULLY PAID |
Materials |
$653 |
Completion of Tranche 2 Placement, SPP and Cleansing Notice
|
23 Dec 2025 9:30AM |
$0.475 |
$0.470 |
fallen by
1.05%
|
|